Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy

被引:24
|
作者
Pierorazio, Phillip M. [1 ]
Kinnaman, Michael D. [1 ]
Wosnitzer, Matthew S. [1 ]
Benson, Mitchell C. [1 ]
McKiernan, James M. [1 ]
Goluboff, Erik T. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Urol, New York, NY USA
关键词
D O I
10.1016/j.urology.2007.05.022
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To more clearly elucidate the relationship between prostate volume (PV) and prostate cancer parameters. METHODS The Urologic Oncology Database was reviewed. A total of 3460 patients had undergone radical prostatectomy from 1988 to 2006. Of these, 2600 with complete data were included in the study and were stratified by the PV: normal (0 to 40 cm(3)), moderate (40 to 80 cm(3)), or large (greater than 80 cm(3)). The prostate cancer variables were evaluated using analysis of variance. Regression models were used to determine the role of PV in Gleason sum discordance (greater than 1 unit) controlling for prostate-specific antigen level and clinical and pathologic stage. RESULTS Of the 2600 patients, 1453 (55.2%) had a normal, 1035 (39.8%) a moderate, and 130 (5.0%) a large PV. Patients with a normal PV were more likely to have a Gleason sum greater than 6 at biopsy (46.2%) and radical retropubic prostatectomy (68,4%) compared with patients with a moderate (39.0% and 58.9%, respectively) or a large (41.5% and 57.7%, respectively) PV (P 0.005 and P = 0.001, respectively). Patients with a normal PV had greater rates of extraprostatic extension (32.3%) and positive margins (28.2%) compared with those with a moderate (25.5% and 22.4%, respectively) or a large (23.3% and 20.3%, respectively) PV (P = 0.002 and P = 0.005, respectively). Of all 2600 patients, 55.9% had no change between the biopsy and pathologic Gleason sum, 255 (9.8%) were downgraded, and 890 (34.3%) were upgraded. Patients with a large PV had a greater rate of downgrading (16.2%) than those with a normal (8.7%) or moderate (10.5%) PV (P = 0.01). Patients upgraded had the greatest rate of pathologically advanced disease (35.3% with Stage T3 or greater, P <0.001). On multivariate regression analysis, PV (odds ratio 0.99, P = 0.005), prostate-specific antigen level (odds ratio 1.03, P <0.001), and age (odds ratio 1.03, P <0.001) were predictors of Gleason discordance +/- 2. CONCLUSIONS The results of our study have shown that patients with a large PV (greater than 80 cm(3)) are more likely to have a lower Gleason sum, locally confined and less-aggressive pathologic disease, and were more often downgraded.
引用
收藏
页码:696 / 701
页数:6
相关论文
共 50 条
  • [21] Outcomes of laparoscopic salvage radical prostatectomy after primary treatment of prostate cancer
    Catarino, Raquel
    Javier Otta-Oshiro, Renan
    Lista-Mateos, Fernando
    Maria Garcia-Mediero, Jose
    Nunez-Mora, Carlos
    [J]. CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (01) : 59 - 64
  • [22] Oncological outcomes after radical prostatectomy and radiotherapy for high risk prostate cancer
    Chiu, P. K. F.
    Tong, S. Y. T.
    Poon, D. M.
    Chan, E. S. Y.
    Hou, S. M.
    Ng, C. F.
    [J]. BJU INTERNATIONAL, 2015, 115 : 7 - 7
  • [23] Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
    Kelkar, Sonia
    Oyekunle, Taofik
    Eisenberg, Adva
    Howard, Lauren
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Klaassen, Zachary
    Terris, Martha K.
    Freedland, Stephen J.
    Csizmadi, Ilona
    [J]. JNCI CANCER SPECTRUM, 2021, 5 (03)
  • [24] The effect of prostate volume on complications after radical retropubic prostatectomy
    Bedir, S
    Kilciler, M
    Erdemir, F
    Coban, H
    Erten, K
    Ozgok, Y
    Peker, AF
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 88 - 89
  • [25] Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
    Jae Won Park
    Dong Hoon Koh
    Won Sik Jang
    Kang Su Cho
    Won Sik Ham
    Koon Ho Rha
    Sung Joon Hong
    Young Deuk Choi
    [J]. BMC Cancer, 18
  • [26] Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
    Park, Jae Won
    Koh, Dong Hoon
    Jang, Won Sik
    Cho, Kang Su
    Ham, Won Sik
    Rha, Koon Ho
    Hong, Sung Joon
    Choi, Young Deuk
    [J]. BMC CANCER, 2018, 18
  • [27] Prostate cancer: radical prostatectomy
    Nelson, JB
    Lepor, H
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (04) : 703 - +
  • [28] The influence of prostate size on perioperative, pathologic and continence outcomes of laparoscopic radical prostatectomy
    Koi, Philip
    Milhoua, Paul
    Knoll, Abraham
    Ghavamian, Reza
    [J]. JOURNAL OF ENDOUROLOGY, 2006, 20 : A156 - A156
  • [29] PATHOLOGIC OUTCOMES OF PATIENTS WITH NEGATIVE MRI UNDERGOING PROSTATE BIOPSY AND RADICAL PROSTATECTOMY
    Oishi, Masakatsu
    Shin, Toshitaka
    Ashrafi, Akbar
    Ohe, Chisato
    Ghodoussipour, Saum
    Lin-Brande, Michael
    Winter, Matthew
    Medina, Luis
    Margaryan, Tigran
    Palmer, Suzanne
    Aron, Manju
    Ukimura, Osamu
    Gill, Inderbir
    Abreu, Andre
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E768 - E768
  • [30] THE IMPACT OF PROSTATE VOLUME ON BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY
    Gandaglia, Giorgio
    Briganti, Alberto
    Moschini, Marco
    Suardi, Nazareno
    Gallina, Andrea
    La Croce, Giovanni
    Capitanio, Umberto
    Nini, Alessandro
    Colombo, Renzo
    Montorsi, Francesco
    Scattoni, Vincenzo
    [J]. ANTICANCER RESEARCH, 2014, 34 (05) : 2662 - 2663